Do Antibacterial Skin Sutures Reduce Surgical Site Infections After Elective Open Abdominal Surgery? - Study Protocol of a Prospective, Randomized Controlled Single Center Trial

Overview

Journal Trials

Publisher Biomed Central

Specialties General Medicine
Pharmacology

Date 2019 Jul 4

PMID 31266520

Citations 4

Authors

Daniel Matz

Saskia Teuteberg

Andrea Wiencierz

Savas Deniz Soysal

Oleg Heizmann

Affiliations

Soon will be listed here.

Abstract

Background: Surgical site infections (SSI) remain one of the most common complications in conventional abdominal surgery with an incidence between 4% and 19% (Sandini et al., Medicine (Baltimore) 95:e4057, 2016) in the literature. It is unclear whether the use of coated suture material for skin closure reduces the risk of SSI. In line with in-vitro results, we hypothesize that the use of antibacterial skin sutures (triclosan-coated poliglecaprone 25) reduces the rate of SSI after open abdominal surgery.

Methods/design: To prevent SSI, triclosan-coated poliglecaprone 25 sutures will be tested against un-coated suture material for skin closure after elective open abdominal surgery of 364 patients. The study is planned as a single-center, prospective randomized controlled trial. Patients will be followed for 30 days after surgery to detect and document wound complications. The rate of SSI after 30 days will be analyzed in both groups.

Discussion: If we can confirm the proposed hypothesis in our study, this could be a promising and feasible approach to lower SSI after open abdominal surgery. By lowering the rate of SSI this might offer a cost-saving and morbidity-reducing procedure.

Trial Registration: German Clinical Trials Register, DRKS00010047 . Registered on 05.01.2017.

Citing Articles

Do Antibacterial Skin Sutures Reduce Surgical Site Infections After Elective Open Abdominal Surgery?-A Prospective, Randomized Controlled Single-Center Trial.

Matz D, Engelhardt S, Wiencierz A, Soysal S, Misteli H, Kirchhoff P J Clin Med. 2024; 13(22).

PMID: 39597947 PMC: 11594667. DOI: 10.3390/jcm13226803.

The role of triclosan-coated suture in preventing surgical infection: A meta-analysis.

He P, Liu Z, Chen H, Huang G, Mao W, Li A Jt Dis Relat Surg. 2023; 34(1):42-49.

PMID: 36700262 PMC: 9903111. DOI: 10.52312/jdrs.2023.842.

From Residues to Added-Value Bacterial Biopolymers as Nanomaterials for Biomedical Applications.

Blanco F, Hernandez N, Rivero-Buceta V, Maestro B, Sanz J, Mato A Nanomaterials (Basel). 2021; 11(6).

PMID: 34200068 PMC: 8228158. DOI: 10.3390/nano11061492.

Natural Cellulose Fibers for Surgical Suture Applications.

Guambo M, Spencer L, Vispo N, Vizuete K, Debut A, Whitehead D Polymers (Basel). 2020; 12(12).

PMID: 33353190 PMC: 7765994. DOI: 10.3390/polym12123042.

References

Mangram A, Horan T, Pearson M, Silver L, Jarvis W . Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999; 20(4):250-78; quiz 279-80. DOI: 10.1086/501620. View

Kirkland K, Briggs J, Trivette S, WILKINSON W, Sexton D . The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999; 20(11):725-30. DOI: 10.1086/501572. View

Jones R, Jampani H, Newman J, Lee A . Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control. 2000; 28(2):184-96. View

Malone D, Genuit T, Tracy J, Gannon C, Napolitano L . Surgical site infections: reanalysis of risk factors. J Surg Res. 2002; 103(1):89-95. DOI: 10.1006/jsre.2001.6343. View

Horan T, Gaynes R, Martone W, Jarvis W, Emori T . CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992; 13(10):606-8. View

Storch M, Rothenburger S, Jacinto G . Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect (Larchmt). 2005; 5(3):281-8. DOI: 10.1089/sur.2004.5.281. View

Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P . Adverse impact of surgical site infections in English hospitals. J Hosp Infect. 2005; 60(2):93-103. DOI: 10.1016/j.jhin.2004.10.019. View

Coskun D, Aytac J, Aydinli A, Bayer A . Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect. 2005; 60(2):176-9. DOI: 10.1016/j.jhin.2004.10.017. View

Ford H, Jones P, Gaines B, Reblock K, Simpkins D . Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL suture (coated polyglactin 910 suture). Surg Infect (Larchmt). 2005; 6(3):313-21. DOI: 10.1089/sur.2005.6.313. View

10.

Weber W, Marti W, Zwahlen M, Misteli H, Rosenthal R, Reck S . The timing of surgical antimicrobial prophylaxis. Ann Surg. 2008; 247(6):918-26. DOI: 10.1097/SLA.0b013e31816c3fec. View

11.

Justinger C, Moussavian M, Schlueter C, Kopp B, Kollmar O, Schilling M . Antibacterial [corrected] coating of abdominal closure sutures and wound infection. Surgery. 2009; 145(3):330-4. DOI: 10.1016/j.surg.2008.11.007. View

12.

Misteli H, Weber W, Reck S, Rosenthal R, Zwahlen M, Fueglistaler P . Surgical glove perforation and the risk of surgical site infection. Arch Surg. 2009; 144(6):553-8. DOI: 10.1001/archsurg.2009.60. View

13.

Chang W, Srinivasa S, Morton R, Hill A . Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg. 2012; 255(5):854-9. DOI: 10.1097/SLA.0b013e31824e7005. View

14.

Edmiston Jr C, Daoud F, Leaper D . Is there an evidence-based argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections?: A meta-analysis. Surgery. 2013; 154(1):89-100. DOI: 10.1016/j.surg.2013.03.008. View

15.

Lawson E, Hall B, Ko C . Risk factors for superficial vs deep/organ-space surgical site infections: implications for quality improvement initiatives. JAMA Surg. 2013; 148(9):849-58. DOI: 10.1001/jamasurg.2013.2925. View

16.

Mujagic E, Zwimpfer T, Marti W, Zwahlen M, Hoffmann H, Kindler C . Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trial. Trials. 2014; 15:188. PMC: 4040488. DOI: 10.1186/1745-6215-15-188. View

17.

Sandini M, Mattavelli I, Nespoli L, Uggeri F, Gianotti L . Systematic review and meta-analysis of sutures coated with triclosan for the prevention of surgical site infection after elective colorectal surgery according to the PRISMA statement. Medicine (Baltimore). 2016; 95(35):e4057. PMC: 5008528. DOI: 10.1097/MD.0000000000004057. View

18.

Wu X, Kubilay N, Ren J, Allegranzi B, Bischoff P, Zayed B . Antimicrobial-coated sutures to decrease surgical site infections: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2016; 36(1):19-32. DOI: 10.1007/s10096-016-2765-y. View

19.

de Jonge S, Atema J, Solomkin J, Boermeester M . Meta-analysis and trial sequential analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg. 2017; 104(2):e118-e133. DOI: 10.1002/bjs.10445. View

20.

Leaper D, Edmiston Jr C, Holy C . Meta-analysis of the potential economic impact following introduction of absorbable antimicrobial sutures. Br J Surg. 2017; 104(2):e134-e144. DOI: 10.1002/bjs.10443. View